Medidata Solutions Inc (MDSO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medidata Solutions Inc (MDSO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10108
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data and analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analytics solutions, using secure cloud and hybrid cloud infrastructure. Medidata’s service portfolio includes implementation, configuration, data testing, and integration support, training, reporting and consultation services for clinical development process. Medidata offers its services to pharmaceutical, biotechnology and medical device companies, academic institutions, and contract research organizations (CROs). The company markets and sells its products through direct sales force, CROs and strategic partners in North America, Europe and Asia. Medidata is headquartered in New York, the US.

Medidata Solutions Inc (MDSO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 10
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Medidata Solutions and Decibel Therapeutics Enter into Agreement 12
Akros Pharma Enters into Agreement with Medidata 13
Auris Medical Enters Into Agreement With Medidata Solutions 14
Acquisition 15
Medidata Solutions Acquired Mytrus 15
Medidata Solutions Inc – Key Competitors 16
Medidata Solutions Inc – Key Employees 17
Medidata Solutions Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Strategy And Business Planning 20
Sep 27, 2017: Medidata Opens New, Larger London EMEA Headquarters 20
Financial Announcements 21
Oct 18, 2018: Medidata announces third quarter 2018 results 21
Jul 24, 2018: Medidata Reports Second Quarter 2018 Results 22
Apr 19, 2018: Medidata Announces First Quarter 2018 Results 23
Feb 08, 2018: Medidata Reports Record Full-Year and Fourth Quarter 2017 Results 24
Oct 26, 2017: Medidata Reports Record Third Quarter 2017 Results 26
Jul 18, 2017: Medidata Reports Record Second Quarter 2017 Results 28
Apr 26, 2017: Medidata Reports Record First Quarter 2017 Results 30
Feb 09, 2017: Medidata Reports Record Full-Year and Fourth Quarter 2016 Results 32
Corporate Communications 34
Oct 23, 2018: Medidata Sets Major New Corporate Social Responsibility (CSR) Commitments 34
Oct 22, 2018: Medidata Appoints Dr.Maria Rivas to its Board of Directors 35
Legal and Regulatory 36
May 08, 2018: Medidata Offers Breakthrough to De-Risk Clinical Trial Submissions 36
Government and Public Interest 37
Jul 26, 2018: Medidata corporate social responsibility initiatives benefit patients, students, and communities 37
Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives 38
Product News 39
Jun 25, 2018: Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden with Medidata 39
Other Significant Developments 40
Feb 20, 2018: Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development 40
Feb 13, 2018: Medidata Introduces New Edge Family of Products for Clinical Operations at SCOPE 2018 41
Jul 20, 2017: “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Medidata Solutions Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 10
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Medidata Solutions and Decibel Therapeutics Enter into Agreement 12
Akros Pharma Enters into Agreement with Medidata 13
Auris Medical Enters Into Agreement With Medidata Solutions 14
Medidata Solutions Acquired Mytrus 15
Medidata Solutions Inc, Key Competitors 16
Medidata Solutions Inc, Key Employees 17
Medidata Solutions Inc, Other Locations 18
Medidata Solutions Inc, Subsidiaries 19

List of Figures
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Medidata Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Medidata Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Medidata Solutions Inc (MDSO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clicks Group Limited:企業の戦略・SWOT・財務分析
    Clicks Group Limited - Strategy, SWOT and Corporate Finance Report Summary Clicks Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Savola Group Co:戦略・SWOT・企業財務分析
    Savola Group Co - Strategy, SWOT and Corporate Finance Report Summary Savola Group Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BBVA:企業のM&A・事業提携・投資動向
    BBVA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BBVA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings …
  • Mindray Medical International Ltd-医療機器分野:企業M&A・提携分析
    Summary Mindray Medical International Ltd (Mindray) is a medical device company. Its major products include multi-parameter patient monitors, telemetry monitoring system, defibrillator, anesthesia machine, surgical lights, ceiling supply units, veterinary monitoring systems, hematology analyzer and …
  • MRC Global Inc (MRC):企業の財務・戦略的SWOT分析
    MRC Global Inc (MRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Saras SpA (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • AbbVie Inc (ABBV):医療機器:M&Aディール及び事業提携情報
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virolo …
  • Essar Power Ltd:企業の戦略的SWOT分析
    Essar Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adh …
  • Somnomed Ltd (SOM):企業の財務・戦略的SWOT分析
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • Heraeus Holding GmbH:企業の戦略・SWOT・財務情報
    Heraeus Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Heraeus Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Steelcase Inc. (SCS):企業の財務・戦略的SWOT分析
    Steelcase Inc. (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務情報
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Electronic Arts Inc. (EA):企業の財務・戦略的SWOT分析
    Electronic Arts Inc. (EA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. The company develops products using its proprietary peripheral arterial tonomet …
  • Calgary Scientific Inc-医療機器分野:企業M&A・提携分析
    Summary Calgary Scientific Inc (Calgary Scientific) is a scientific software company that provides technology solutions for the medical industry. The company offers ResolutionMD, a diagnostic medical imaging software solution that acts as an enterprise image viewer for doctors to view patient images …
  • ProAxsis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Teekay LNG Partners LP:企業のM&A・事業提携・投資動向
    Teekay LNG Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teekay LNG Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Marathon Petroleum Corporation:企業の戦略・SWOT・財務情報
    Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • China Longyuan Power Group Corp Ltd (916):企業の財務・戦略的SWOT分析
    China Longyuan Power Group Corp Ltd (916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆